B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis

Published:2014-07 Issue:7 Volume:9 Page:1036-1040
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Mansfield Aaron Scott,Roden Anja C.,Peikert Tobias,Sheinin Yuri M.,Harrington Susan M.,Krco Christopher J.,Dong Haidong,Kwon Eugene D.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008;Henley;Int J Occup Environ Health,2013

2. The worldwide pandemic of asbestos-related diseases;Stayner;Annu Rev Public Health,2013

3. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses;Sterman;Clin Cancer Res,2007

4. Lymphocytic infiltration of pleural mesothelioma and its significance for survival;Leigh;S Afr Med J,1982

5. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion;Dong;Nat Med,1999

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma;Lung Cancer;2024-09

2. Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights;Open Respiratory Archives;2024-07

3. Therapeutic Strategies to Improve the Treatment of Pleural Mesothelioma;Current Medicinal Chemistry;2024-04-16

4. Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy;Cancers;2023-12-10

5. Targeting the epigenome to reinvigorate T cells for cancer immunotherapy;Military Medical Research;2023-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3